Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.
…
continue reading
1
China Biotech Podcast - 26 June 2024 (Chinese language)
26:26
26:26
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
26:26
Guest speaker “Angus” Shipo Xie of Hankun Law joins Brian Yang to discuss new overseas data transfer rules, while Dexter Yan explains China biotechs' Hutchmed, Jiangsu Hengrui and Innovbent Bio’s clinical data readouts at the recent EHA and ADA annual meetings.Citeline
…
continue reading
1
Scrip's Five Must-Know Things - 24 June 2024
16:37
16:37
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
16:37
Audio roundup of selected biopharma industry content from Scrip over the business week ended 21 June 2024. In this episode: the outlook for 2025 launches; Merck confident in new pneumococcal vaccine; multiple US setbacks for Japanese firms; Stock Watch on Moderna missteps; and Sun’s North America head talks plans and strategy.https://scrip.citeline…
…
continue reading
1
Lung Life AI's CEO Shares Regulatory And Reimbursement Journey For Lung Cancer Diagnostic, Lung LB
26:24
26:24
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
26:24
In this episode, Medtech Insight reporter Natasha Barrow speaks to LungLife AI CEO Paul Pagano. Lung Life AI is a US-based AIM-listed medical technology company that has developed a liquid biopsy test for the early detection of lung cancer called Lung LB. Pagano runs through the highlights of Lung Life AI’s journey to date and its future ambition f…
…
continue reading
1
The Power Of Herbs For Women’s Wellness, With The SABI’s Hilary Metcalfe and Anna Cave-Bigley
35:21
35:21
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
35:21
In this episode, HBW Insight chats with women’s health start-up The SABI about the power of herbal medicine for hormonal wellness. “Inspired by a series of painfully honest conversations they had about their hormonal and emotional challenges,” The SABI markets a range of herbal infusions aimed at alleviating some of the impacts of painful periods a…
…
continue reading
1
Scrip's Five Must-Know Things - 17 June 2024
15:45
15:45
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
15:45
Audio roundup of selected biopharma industry content from Scrip over the business week ended 14 June 2024. In this episode: Boehringer best in MASH?; biopharma funding on an upswing?; Moderna’s combo jab; clinical trial recover from pandemic; and Astellas’s US commercial head speaks. https://scrip.citeline.com/SC150442/Quick-Listen-Scrips-Five-Must…
…
continue reading
1
Building And Scaling Your Workforce: The Importance Of A Flexible Delivery Model In 2024 & Beyond
22:44
22:44
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
22:44
In this podcast, Janelle Hart, Managing Editor, Citeline, joins industry experts Jessica Wall, Director of Talent Acquisition, and Morgan Seaman, Associate Director of FSS Operations, both from Advanced Clinical, to discuss the latest trends and challenges in building, scaling and differentiating workforces in the life sciences sector.Talent acquis…
…
continue reading
1
June 2024 Datamonitor Healthcare Podcast: ASCO 2024
43:35
43:35
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
43:35
The oncology team from Datamonitor Healthcare and healthcare journalist, Alaric, provide broad analytical coverage of key highlights from the ASCO 2024 conference.Apple Podcasts - https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836Google Podcasts - https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zb3VuZGNsb3VkLmNvbS…
…
continue reading
1
China Biotech Podcast - 14 June 2024 (Bilingual Chinese/English)
27:10
27:10
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
27:10
Guest speaker, US-based Pink Sheet senior writer Sarah Karlin-Smith, joins Brian Yang and Dexter Yan in China to discuss the recent BIO Conference, updates to the planned US BIOSECURE Act and industry preparations for its impact. Dexter also discusses China biotech's data highlights from ASCO 2024.https://scrip.citeline.com/SC150438/China-Biotech-P…
…
continue reading
글로벌 제약업계는 암 연구의 미래를 어떻게 보고 있을까? Scrip의 ASCO 현장 취재 기사를 요약한 내용입니다.https://scrip.citeline.com/SC150378/ASCO-Roundup-Looking-For-The-Future-Of-Cancer-ResearchPlaylist: https://soundcloud.com/citelinesounds/sets/korean-language-biopharma-miniCiteline
…
continue reading
1
Scrip's Five Must-Know Things - 10 June 2024
15:38
15:38
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
15:38
Audio roundup of selected biopharma industry content from Scrip over the business week ended 7 June 2024. In this episode: BIO Notebook; ASCO roundup; data on Carvykti in community at ASCO; strong new results for tirzepatide in MASH; and orphan slowdown signals new path ahead.https://scrip.citeline.com/SC150401/Quick-Listen-Scrips-Five-MustKnow-Thi…
…
continue reading
1
The Generics Bulletin Podcast: Teva, Sandoz, Sawai and US Orange Book patents
24:18
24:18
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
24:18
Generics Bulletin's editorial team discusses the latest strategic developments for major industry players Teva, Sandoz and Sawai, as well as explaining the recent debate over US patent listings in the FDA's Orange Book.Citeline
…
continue reading
1
China Biotech Podcast - 5 June 2024 (Chinese language)
23:09
23:09
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
23:09
Guest speaker Guangzuo Luo, chief scientific officer of Bioncetech, joins China-based editors Brian Yang and Dexter Yan in this episode, which looks at Chinese biotechs going global, and the opportunities and challenges in the latest industry latest trends.https://scrip.citeline.com/SC150370/China-Biotech-Podcast-Going-Global-Trends-Rare-Disease-Dr…
…
continue reading
1
JB CEO On CDMO Growth, Red Sea Crisis And More
34:06
34:06
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
34:06
In an interview with Scrip, JB CEO Nikhil Chopra addresses rumours of a sale of a stake in the Indian pharma/CDMO company by private equity fund KKR, recent acquisitions, including from Novartis, as well as JB's ambitions to ramp up the cardiology segment and its CDMO business, which already has major clients including J&J.https://scrip.citeline.co…
…
continue reading
1
Scrip's Five Must-Know Things - 3 June 2024
15:09
15:09
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
15:09
Audio roundup of selected biopharma industry content from Scrip over the business week ended 31 May 2024. In this episode: ASCO preview; Asahi’s US acquisition; Novartis aims for renal disease dominance; paying for gene therapies; and US BIOSECURE Act diluted.https://scrip.citeline.com/SC150361/Quick-Listen-Scrips-Five-MustKnow-ThingsPlaylist: http…
…
continue reading
1
The Scrip Awards Podcast. Episode 1: Genmab: The Ongoing Evolution Of Europe’s Antibody Powerhouse
22:15
22:15
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
22:15
An interview with Genmab’s Jan van de Winkel to mark 25 years of the company, and 20 years of the Scrip Awards. A brief history of the antibody-focused biotech company so far, and its plans for future expansion.Citeline
…
continue reading
1
How Corporate Sustainability Reporting ‘Just Got Serious,’ With CEN-ESG’s Jasper Crone
50:18
50:18
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
50:18
In this episode we unpack the Corporate Sustainability Reporting Directive (CSRD) with the help of ESG expert Jasper Crone, drilling down into exactly what consumer healthcare companies need to know about this enormously complex and significant piece of EU legislation.3:30 Introduction to the CSRD7:45 What companies are affected by the CSRD15:00 Sp…
…
continue reading
1
Navigating IND Applications & Pre-IND Meetings: Key Considerations And Misconceptions
37:01
37:01
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
37:01
Advancing Investigational New Drugs (INDs) can be a complex process, especially for smaller companies. Listen to your free podcast now as Marcus Delatte, PhD, Vice President at Allucent and Harshini Neelakantan, Executive Director at Ridgeline Therapeutics discuss best practices and considerations for leveraging your pre-IND meeting and submitting …
…
continue reading
1
'CorpPharma Is Not Just A Cost Component’ – Showcasing Value As Well As Innovation
35:52
35:52
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
35:52
Astellas Pharma’s chief commercial officer, Claus Zieler, discusses the biopharma industry’s responsibility to drive change in health care.Citeline
…
continue reading
1
China Biotech CEO Interview - NeuShen's Joan Huaqiong Shen
45:35
45:35
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
45:35
NeuShen CEO Joan Shen discusses with Brian Yang about developing CNS drugs in China, the venture's business rationale, challenges and fundraising. She also discusses two leading assets for schizophrenia and epilepsy in first-in-human studies, as well as a gene therapy collaboration for ALS with UMass's Gao Lab.https://scrip.citeline.com/SC150328/Ch…
…
continue reading
As the 15 July entry deadline for the 3rd edition of the annual Citeline Japan Awards approaches, join us in this bilingual English/Japanese podcast to learn more about the categories and event itself. (Japanese starts at 2' 25".)English event site: https://www.citeline.com/en/awards/citelinejapanawardsJapanese event site: https://www.citeline.com/…
…
continue reading
1
Scrip's Five Must-Know Things - 27 May 2024
16:00
16:00
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
16:00
Audio roundup of selected biopharma industry content from Scrip over the business week ended 24 May 2024. In this episode: Biogen’s immunology acquisition; AstraZeneca looks to cement respiratory lead; why US FTC is tough on pharma; the US election’s impact on pharma; and how new AI tools are impacting medical affairs.https://scrip.citeline.com/SC1…
…
continue reading
1
Drug Fix: Novel Clinical Trial Reg Problems, NIH Drug ‘Access Plans’, Good Ole Days Of Woodcock
23:09
23:09
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
23:09
Pink Sheet editors discuss the US FDA’s consideration of regulatory changes to promote innovative clinical trial designs (:32), an NIH proposal to require patent licensees create plans to ensure access to the commercialized product (7:29), and lawmakers longing for the days when Janet Woodcock ran the FDA’s Center for Drug Evaluation and Research (…
…
continue reading
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。今回取り上げた記事はこちら「Hibernating Squirrels And Exercise In A Pill: The Next Wave of Cardiometabolic Therapies( 邦題意訳:GLP-1を超える心代謝系治療薬のヒントは、冬眠するリスか、地道な運動か)」(日本語版)https://www.citeline.com/ja-jp/resources/hibernating-squirrels-and-exercise-in-a-pill※全文の閲覧には情…
…
continue reading
1
Closed Loop Medicine: Pairing Software With Drugs To Optimize Dosing
25:21
25:21
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
25:21
In this episode of the In Vivo podcast, Hakim Yadi, CEO and co-founder of UK techbio company Closed Loop Medicine, discusses how his company is pairing software and predictive analytics with medications old and new to tailor drug dosing to each patient.Citeline
…
continue reading
1
Leading PRO Discusses Plans For Administering State EPR Programs
36:59
36:59
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
36:59
In this episode, HBW chats with John Hite of the leading producer responsibility organization administering three Extended Producer Responsibility laws launching next year. With a 1 July deadline to register for his PRO, Circular Action Alliance, Hite discusses steps companies should take now, how his organization will assist producers and expectat…
…
continue reading
빅파마 기업들의 블록버스터 신약 확보 전략에 대한 Scrip 기사를 요약한 내용입니다.https://scrip.citeline.com/SC150256/Development-Versus-Dealmaking-How-To-Obtain-A-BlockbusterPlaylist: https://soundcloud.com/citelinesounds/sets/korean-language-biopharma-miniCiteline
…
continue reading
1
How To Grow A Consumer Health Brand, With TheOTCLab’s Albert Swane
32:07
32:07
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
32:07
In this episode, HBW Insight catches up with Albert Swane, founder and CEO of Dutch consumer healthcare firm, TheOTCLab, to talk about business strategy. Having grown the company with widely successful European OTC medical devices like Dr. Yglo, FungeX and Kidsner, Swane is perfectly placed to explain how to create and grow OTC brands. Swane also o…
…
continue reading
1
Scrip's Five Must-Know Things - 20 May 2024
16:55
16:55
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
16:55
Audio roundup of selected biopharma industry content from Scrip over the business week ended 17 May 2024. In this episode: the life of a blockbuster; blockbusters by indication; gene therapy struggles; sun shines on AstraZeneca and GSK; and Korean ventures look to Japan.https://scrip.citeline.com/SC150281/Quick-Listen-Scrips-Five-MustKnow-ThingsPla…
…
continue reading
1
Drug Fix: BIOSECURE Act Advances, Trial Diversity Sticks, Platform Principles Without Designation
38:55
38:55
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
38:55
Pink Sheet editors and reporter consider the implications of the BIOSECURE Act as it advances through a House committee (:30), whether industry would improve clinical trial diversity with tougher enforcement of the regulation (22:26), as some have suggested, and the FDA’s use of platform technology ideas for gene therapies not participating in the …
…
continue reading
1
May 2024 Datamonitor Healthcare Podcast: Neoadjuvant Therapy in Melanoma
16:04
16:04
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
16:04
Flora gives an overview of the budding landscape of neoadjuvant therapy in melanoma and provides insight on the nuances of this market.Apple Podcasts - https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836Google Podcasts - https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zb3VuZGNsb3VkLmNvbS91c2Vycy9zb3VuZGNsb3VkOnVzZX…
…
continue reading
1
China Biotech Podcast - 15 May 2024 (Chinese- and English-Language)
35:28
35:28
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
35:28
In this bilingual Chinese- and English-language edition, China-based editors Brian Yang and Dexter Yan, along with guest speaker Derrick Gingery from the Pink Sheet in the US, discuss the planned US BIOSECURE Act and markup vote. Brian and Dexter also look at recent R&D updates from Chinese biopharma firms on their antibody-drug conjugate pipelines…
…
continue reading
1
Scrip's Five Must-Know Things - 13 May 2024
14:29
14:29
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
14:29
Audio roundup of selected biopharma industry content from Scrip over the business week ended 10 May 2024. In this episode: AstraZeneca’s Vaxzevria farewell; the next wave of cardiometabolics; Pfizer recruits prominent analyst: foundation pleas for China rare disease therapies; and Gossamer partners up for respiratory therapy.https://scrip.citeline.…
…
continue reading
1
Episode 15: Digital Trust
20:20
20:20
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
20:20
In this episode, Medtech Insight senior reporter Hannah Daniel speaks to Mark Brown, Global Managing Director of Digital Trust Consulting at the British Standards Institute about digital trust. In a world of cybersecurity breaches and ransomware attacks on hospitals, digital trust between companies and consumers is key, but current siloed operation…
…
continue reading
1
Solving The Sustainable Pill Pack Puzzle, With PA Consulting’s Tony Perrotta
29:28
29:28
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
29:28
In this episode, HBW Insight chats with sustainable packaging expert Tony Perrotta about why it’s so difficult to replace plastic pill packs in medicines packaging. Perrotta works for PA Consulting, which set up the Blister Pack Collective alongside consumer healthcare partners Haleon, Bayer and Sanofi. They are working with PulPac, which has inven…
…
continue reading
1
Scrip's Five Must-Know Things - 7 May 2024
15:01
15:01
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
15:01
Audio roundup of selected biopharma industry content from Scrip over the business week ended 3 May 2024. In this episode: Japan’s Ono buys US oncology firm; strong growth but supply issues for Lilly; Novo and Lilly make their money work; BMS cuts jobs, costs; and Big Pharma’s support for bioventures.https://scrip.citeline.com/SC150211/Quick-Listen-…
…
continue reading
1
Drug Fix: US FDA Adcomm Reform, A Boost For Clinical Trial Modeling, AI For Drug Review
31:23
31:23
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
31:23
Pink Sheet reporter and editors discuss what an upcoming listening session means for the FDA’s advisory committee reform effort (:32), the agency’s efforts to help the clinical trial modeling and simulation industry (16:22), and the UK’s MHRA plan to use artificial intelligence to assist in drug application reviews (21:05).More On These Topics From…
…
continue reading
1
Digital Health Roundup: US FDA’s ‘Idea Lab’; Philips’ Roy Jakobs On AI Draft Framework; Apple Watch
6:35
In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights key interviews with Philips’ CEO Roy Jakobs on NAM’s draft framework on AI, BD’s CTO Beth McCombs R&D initiatives and HSS spine co-chair Sheeraz Qureshi on his vision for integrating AI tech. Hannah Daniel discusses the FDA’s new initiative to create an idea lab for me…
…
continue reading
1
April Datamonitor Podcast 2024: AAN coverage
51:54
51:54
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
51:54
Flora and Emma are joined by Datamonitor’s CNS analysts Summer, Joseph, and Wen-Yu to discuss coverage from AAN.Other platforms (in addition to SoundCloud):Apple Podcasts - https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836Google Podcasts - https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zb3VuZGNsb3VkLmNvbS91c2Vy…
…
continue reading
1
Scrip's Five Must-Know Things - 30 April 2024
14:15
14:15
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
14:15
Audio roundup of selected biopharma industry content from Scrip over the business week ended 26 April 2024. In this episode: 2023’s top selling drugs and the COVID cliff; falling sales force Roche to reassess priorities; Phase III immunology win for Sanofi; BMS’s strong pipeline: and which companies could be acquired next.https://scrip.citeline.com…
…
continue reading
2024 Global Generics & Biosimilars Awards by CitelineCiteline
…
continue reading
1
Podcast: Facilitating Patient Monitoring in CAR-T Development
19:28
19:28
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
19:28
Learn how molecular technology is enhancing patient safety for CAR-T clinical trials. US FDA recently initiated class safety labeling changes after evaluating the safety of CAR-T cancer treatment therapies. What does this mean for developers in the CAR-T landscape? Listen to your free podcast to find out.Listen in on the conversation as experts fro…
…
continue reading
1
Drug Fix: US FDA Biosimilar Strategy, Gene Therapy Accelerated Approvals, FDA v. Partisan Politics
34:14
34:14
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
34:14
Pink Sheet reporter and editors discuss the impact of FDA biosimilar promotion guidance on the future of the interchangeability designation (:34), upcoming guidance on accelerated approval for gene therapies (14:15), and partisan attacks on the agency from Capitol Hill (27:13).More On These Topics From The Pink SheetRx Advertising: Interchangeabili…
…
continue reading
1
Dr. Xue Discusses Treatment Guideline Updates for COPD in This Q&A Session
10:15
10:15
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
10:15
Pulmonologist Bing Xue, MD, reviews the latest GOLD guidelines and discusses relevant topics regarding COPD treatment.Citeline
…
continue reading
1
China Biotech Podcast - 26 April 2024 (Chinese and English Language)
28:19
28:19
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
28:19
Join Scrip's China-based editors Brian Yang and Dexter Yan in this Chinese/English podcast as they look at data presented to AACR by Chinese pharma firms and recent acquisitions of China-based companies. UK-based writer Andrew McConaghie also joins to provide his perspectives, including on the proposed US BIOSECURE Act.https://scrip.citeline.com/SC…
…
continue reading
1
Future Governance & Oversight of the EU Medtech Regulatory System
55:58
55:58
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
55:58
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.Citeline
…
continue reading
1
Citeline - Cerba Research Podcast V2
19:28
19:28
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
19:28
Citeline - Cerba Research Podcast V2 by CitelineCiteline
…
continue reading
1
Scrip M&A Podcast: Are Buyers Coming For Viking, Verona, Altimmune, Xenon And Crinetics
45:57
45:57
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
45:57
Scrip's Joseph Haas, Kevin Grogan and Edwin Elmhirst talk about the biopharma M&A environment and which companies might look particularly appealing to potential acquirers.Citeline
…
continue reading
1
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
18:38
18:38
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
18:38
In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.Citeline
…
continue reading
1
Over The Counter 22 April 2024
22:13
22:13
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
22:13
Helping Consumers ‘Tune In’ To Reliable Health Information, With Kaizo’s Anita Nahal“Consumers are rewriting the rules when it comes to where they are going for information and the type of information they are looking for,” reports Kaizo’s Anita Nahal, speaking to HBW Insight’s Over the Counter podcast about the agency’s latest Communicating Health…
…
continue reading
1
Scrip's Five Must-Know Things - 22 April 2024
14:54
14:54
Прослушать позже
Прослушать позже
Списки
Нравится
Нравится
14:54
Audio roundup of selected biopharma industry content from Scrip over the business week ended 19 April 2024. In this episode: Teva’s immunology biosimilar launches; Intra-Cellular’s promising depression data; Phase III sleep apnea win for Lilly’s tirzepatide; an interview with Viking’s CEO; and China looks to define innovative drugs.https://scrip.ci…
…
continue reading